June 16, 2008 – Siemens introduced IQ•SPECT, a works-in-progress that is the newest Symbia feature that enables a comprehensive cardiac evaluation including perfusion, attenuation correction and calcium scoring, in five minutes.

IQ•SPECT technology is achieved with SMARTZOOM, a specially designed “smart” collimator that magnifies the heart while imaging the rest of the torso under traditional conditions. Typically, cardiac SPECT data is obtained through keeping the detectors positioned at 90 degrees and as close to the body as possible, utilizing mechanically centered detector rotation, where organ specific magnification cannot be achieved.

The flexible mechanics of the Symbia S and T gantries allow an organ centric detector rotation that can zero-in on the organ of interest; in this case, the heart. Combining this organ centric orbit acquisition technique, fast, 3D iterative reconstruction that is optimized for more confident diagnoses, and improved patient comfort from a quicker scan, IQ•SPECT will set the standard for image quality, speed, productivity and throughput.

IQ•SPECT will be available for all new Symbia S and T systems, and is field upgradeable for any existing Symbia S or T systems that are already widely available in leading hospitals and imaging centers across the globe. The new SMARTZOOM feature is integrated into the current Symbia workflows and automation features, giving users access to the most flexible and versatile system available today.

From a user perspective, IQ•SPECT is fully automated and can therefore accommodate more patients per day and meet a variety of patient needs. For example, pediatric patients can benefit from a lower injected dose in regular acquisition time, or from less motion and more comfort with a regular dose and quicker acquisition time. A quicker scan allows for less patient movement and lowers the probability of retakes.

For more information: www.usa.siemens.com/medical


Related Content

News | SPECT Imaging

February 15, 2024 — According to a release issued by the U.S. Food and Drug Administration (FDA), Philips is recalling ...

Time February 15, 2024
arrow
News | FDA

January 23, 2024 — Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of syngo Virtual ...

Time January 23, 2024
arrow
News | Radiopharmaceuticals and Tracers

June 19, 2023 — NorthStar Medical Technologies, LLC, a global innovator in the development, production and ...

Time June 19, 2023
arrow
News | Nuclear Imaging

February 23, 2023 — Editor's note: This news item has been updated to reflect that the FDA has since updated its alert ...

Time February 15, 2023
arrow
News | SPECT-CT

September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...

Time September 12, 2022
arrow
News | SPECT-CT

June 13, 2022 — Siemens Healthineers has announced the Food and Drug Administration (FDA) clearance of the Symbia Pro ...

Time June 13, 2022
arrow
News | Prostate Cancer

June 10, 2022 — GE Healthcare provides cutting-edge molecular imaging solutions that enable and increase access to ...

Time June 10, 2022
arrow
News | SPECT-CT

March 11, 2022 — The world of medical imaging is no longer just black and white. NeuroLogica Corp., a subsidiary of ...

Time March 11, 2022
arrow
Sponsored Content | Videos | Computed Tomography (CT)

At RSNA 2021, Philips highlighted the launch of two new innovative CT systems – the multi-energy Spectral CT 7500 and ...

Time March 09, 2022
arrow
News | Molecular Imaging

December 29, 2021 — The global nuclear imaging devices and equipment market is expected to grow from $2.45 billion in ...

Time December 29, 2021
arrow
Subscribe Now